Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA approvals February 2026 The FDA's Current Position on Peptides Explained Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like